ARM
TRIB

Adirondack Research & Management’s Trinity Biotech TRIB Stock Holding History

Adirondack Research & Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-70,617
Closed -$365K – 96
2019
Q4 		$365K Sell
70,617
-12,526
-15% -$59.6K 0.32% 70
2019
Q3 		$503K Sell
83,143
-21,795
-21% -$189K 0.44% 63
2019
Q2 		$866K Sell
104,938
-5,552
-5% -$66K 0.62% 49
2019
Q1 		$1.57M Sell
110,490
-3,317
-3% -$45.6K 0.98% 37
2018
Q4 		$1.3M Buy
113,807
+1,748
+2% +$27K 0.81% 44
2018
Q3 		$2.24M Buy
112,059
+9,456
+9% +$205K 0.84% 51
2018
Q2 		$2.56M Buy
102,603
+20,936
+26% +$504K 1% 43
2018
Q1 		$2.1M Hold
81,667
– – 0.84% 48
2017
Q4 		$2.08M Buy
81,667
+14,832
+22% +$382K 0.82% 51
2017
Q3 		$1.88M Buy
66,835
+2,638
+4% +$73.6K 0.73% 50
2017
Q2 		$1.93M Hold
64,197
– – 0.75% 52
2017
Q1 		$1.91M Buy
64,197
+9,170
+17% +$287K 0.69% 54
2016
Q4 		$1.9M Sell
55,027
-28,044
-34% -$966K 0.65% 56
2016
Q3 		$5.49M Hold
83,071
– – 1.98% 17
2016
Q2 		$4.71M Hold
83,071
– – 1.77% 17
2016
Q1 		$4.84M Buy
83,071
+1,094
+1% +$58.1K 1.76% 16
2015
Q4 		$4.82M Buy
81,977
+21,516
+36% +$1.27M 1.74% 21
2015
Q3 		$3.46M Buy
60,461
+1,660
+3% +$134K 1.33% 37
2015
Q2 		$5.31M Buy
58,801
+13,391
+29% +$1.16M 1.95% 16
2015
Q1 		$4.37M Sell
45,410
-4,000
-8% -$370K 1.69% 25
2014
Q4 		$4.33M Buy
49,410
+5,282
+12% +$455K 1.62% 21
2014
Q3 		$4.03M Buy
44,128
+7,200
+19% +$780K 1.5% 27
2014
Q2 		$4.25M Buy
36,928
+4,627
+14% +$548K 1.44% 30
2014
Q1 		$3.91M Hold
32,301
– – 1.5% 27
2013
Q4 		$4.06M Hold
32,301
– – 1.97% 9
2013
Q3 		$3.51M Hold
32,301
– – 2.02% 5
2013
Q2 		$2.72M Buy
+32,301
New +$2.68M 2.03% 5

Other funds holding TRIB

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Adirondack Research & Management's TRIB Position: Q1 2020 in Review

Adirondack Research & Management sold out of Trinity Biotech (TRIB) in Q1 2020, closing a stake of 70,617 shares — an estimated $365K sold.

Adirondack Research & Management first reported a position in TRIB in Q2 2013 and held it in 27 quarters. The position peaked at $5.49M in Q3 2016. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2020.

  • Adirondack Research & Management reported no remaining Trinity Biotech position as of Q1 2020 after selling out during the quarter.
  • Adirondack Research & Management sold 70,617 Trinity Biotech shares in Q1 2020, an estimated $365K.
  • Adirondack Research & Management first reported a position in Trinity Biotech in Q2 2013 and held it in 27 quarters.
  • Adirondack Research & Management's Trinity Biotech position peaked at $5.49M in Q3 2016.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2020.

Based on Adirondack Research & Management's 13F filing for Q1 2020, filed 13 May 2020.